(Q35570030)

8 August 2017

1 reference

title

A benefit-risk assessment of sibutramine in the management of obesity (English)

1 reference

8 August 2017

0 references

1 reference

Enzo Nisoli

1

0 references

author name string

Michele O Carruba

series ordinal

2

1 reference

8 August 2017

1 January 2003

1 reference

8 August 2017

1 reference

8 August 2017

26

1 reference

8 August 2017

14

1 reference

8 August 2017

1027-1048

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200326140-00004

8 August 2017

0 references

cites work

Energy expenditure, physical activity, and obesity in children

1 reference

12 December 2020

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

12 December 2020

A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity

1 reference

12 December 2020

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

1 reference

12 December 2020

Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines

1 reference

12 December 2020

Obesity and the environment: where do we go from here?

1 reference

12 December 2020

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

12 December 2020

Pharmaceutical treatment of obesity.

1 reference

12 December 2020

Sibutramine. A review of its contribution to the management of obesity.

1 reference

12 December 2020

Medical hazards of obesity

1 reference

12 December 2020

Sibutramine and thermogenesis in humans

1 reference

12 December 2020

Epidemic increase in childhood overweight, 1986-1998.

1 reference

12 December 2020

Sibutramine--a review of clinical efficacy

1 reference

12 December 2020

Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake.

1 reference

12 December 2020

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

1 reference

12 December 2020

Prevalence and trends in overweight among US children and adolescents, 1999-2000

1 reference

12 December 2020

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

1 reference

12 December 2020

Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial

1 reference

12 December 2020

Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins

1 reference

12 December 2020

Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up

1 reference

12 December 2020

Sibutramine produces dose-related weight loss

1 reference

12 December 2020

Sibutramine reduces food intake in non-dieting women with obesity

1 reference

12 December 2020

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

1 reference

12 December 2020

Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy

1 reference

12 December 2020

The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment.

1 reference

12 December 2020

Sibutramine: a review of the pharmacology of a novel anti-obesity agent

1 reference

12 December 2020

Drugs of abuse: biochemical surrogates of specific aspects of natural reward?

1 reference

12 December 2020

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

12 December 2020

Height, weight, and body mass index of American Indian schoolchildren, 1990-1991.

1 reference

12 December 2020

Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats

1 reference

12 December 2020

Thermogenic effects of sibutramine in humans

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

A comparison of sibutramine and dexfenfluramine in the treatment of obesity

1 reference

12 December 2020

Appetite suppressants. A review

1 reference

12 December 2020

An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action

1 reference

12 December 2020

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

1 reference

12 December 2020

Appetite-suppressant drugs and primary pulmonary hypertension

1 reference

12 December 2020

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

1 reference

12 December 2020

The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females

1 reference

12 December 2020

Signals that regulate food intake and energy homeostasis.

1 reference

12 December 2020

Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older

1 reference

12 December 2020

Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine

1 reference

12 December 2020

Childhood obesity: the health issue

1 reference

12 December 2020

Drug treatment of obesity

1 reference

12 December 2020

Relation between mothers' child-feeding practices and children's adiposity

1 reference

12 December 2020

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

1 reference

12 December 2020

A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin

1 reference

12 December 2020

How does sibutramine work?

1 reference

12 December 2020

Reducing children's television viewing to prevent obesity: a randomized controlled trial

1 reference

12 December 2020

The benefits of modest weight loss in type II diabetes

1 reference

12 December 2020

Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control

1 reference

12 December 2020

Sibutramine in weight control: a dose-ranging, efficacy study

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Body Weight and Mortality among Women

1 reference

12 December 2020

Absence of cardiac valve dysfunction in obese patients treated with sibutramine.

1 reference

12 December 2020

Economic burden of obesity in youths aged 6 to 17 years: 1979-1999.

1 reference

12 December 2020

Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

1 reference

12 December 2020

Guidelines for the approval and use of drugs to treat obesity. A position paper of The North American Association for the Study of Obesity

1 reference

12 December 2020

Abuse liability assessment of sibutramine, a novel weight control agent

1 reference

12 December 2020

New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

Pharmacotherapy for obesity -- do the benefits outweigh the risks?

1 reference

12 December 2020

Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment

1 reference

12 December 2020

Thermogenic effects of sibutramine and its metabolites

1 reference

12 December 2020

The discovery and status of sibutramine as an anti-obesity drug

1 reference

12 December 2020

Paradoxical effect of sibutramine on autonomic cardiovascular regulation

1 reference

12 December 2020

Environmental contributions to the obesity epidemic

1 reference

12 December 2020

Phenylpropanolamine and the risk of hemorrhagic stroke

1 reference

12 December 2020

Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.

1 reference

12 December 2020

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

1 reference

12 December 2020

A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine

1 reference

12 December 2020

Effects of sibutramine on resting metabolic rate and weight loss in overweight women

1 reference

12 December 2020

Assessment of abuse liability of stimulant drugs in humans: a methodological survey

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients

1 reference

12 December 2020

Sibutramine in overweight/obese hypertensive patients

1 reference

12 December 2020

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine

1 reference

12 December 2020

Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies

1 reference

12 December 2020

Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers

1 reference

12 December 2020

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

10.2165/00002018-200326140-00004

Identifiers

DOI

1 reference

PubMed ID

14583064

Dimensions Publication ID

8 August 2017

0 references

1 reference

PubMed ID

14583064